Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-TAT-2022-1000x250px-Online

Platinum Sponsors

Daiichi Sankyo

SL-Daiichi-Sankyo-Astrazeneca

In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. 

AstraZeneca

SL-Daiichi-Sankyo-Astrazeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. 

Gold Sponsors

Loxo Oncology at Lilly

SL-Loxo-at-Lilly

For over 50 years, Lilly has been dedicated to delivering life-changing medicines to people living with cancer. Lilly is determined to continue making life better for all those affected by cancer. In 2019 Lilly created Loxo Oncology at Lilly, with the goal of rapidly delivering impactful new medicines for patients. Our approach centers on creating new medicines that unequivocally work in early clinical development and will matter to patients.

Sanofi Genzyme

SL-Sanofi-Genzyme

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

Educational Grant Sponsors

AstraZeneca

SL-AstraZeneca

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

Bristol Myers Squibb  

SL-Bristol-Myers-Squibb

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science. 

Janssen Oncology

SL-Janssen

At Janssen Oncology, our purpose is to make cancer a manageable and, ultimately, curable condition. We understand that the power to change the lives of those living with cancer begins with a very considered step forwards. Whether it’s from finding novel solutions, a new indication approval, or even just reaching one more patient. That’s The Power of Purpose™.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.